Primary Care / Health Services Research : Family Medicine Center for Clinical Research (FMCCR)

Family Medicine Center for Clinical Research (FMCCR)

The Center for Clinical Research is a University of Miami facility where Family Medicine faculty physicians perform clinical research and provide medical attention to thousands of Miami residents each year. We strive to make a difference in South Florida by making valuable research projects available to a great number of primary care patients. For more information visit the Thomson Centerwatch Profile. (LINK BROKEN).

Current Studies

Name of Compound/Drug M10097
Protocol Title Efficacy and Safety of 2mg/day of M100907 on Sleep Maintenance Insomnia with a Sub-Study of the Effect of M10097 on Stable Type II Diabetes Mellitus: A One Year, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study.
Sponsor Sanofi Aventis
Clinical Research Org Sanofi Aventis
Protocol Number LTE6673
Site Investigator R. Schwartz, MD
Status Active Enrolling

Name of Compound/Drug n/a
Protocol Title A Multi-Center Prospective Clinical Study to Evaluate the Performance and Clinical Predictive Value of the Invader® HPV HR Molecular Assay and Invader® HPV 16/18 Molecular Assay for the Detection of Human Papillomavirus in Cervical Cytology Studies
Sponsor Third Wave Technologies, Madison, WI
Clinical Research Org Health Decisions, Inc., Chapel Hill, NC
Protocol Number TWT DP0517
Site Investigator R. Schwartz, MD
Status Active Enrolling
Name of Compound/Drug SYMBICORT® pMDI
Protocol Title A 12-week, randomized, double-blind, double dummy, multi-center, phase IV study comparing the efficacy and safety of SYMBICORT® pMDI 160/4.5 µg x 2 actuations twice daily versus budesonide inhalation powder DPI 180 µg x 2 inhalations twice daily, in adult and adolescent (=12 years) African American subjects with asthma.
Sponsor AstraZeneca
Clinical Research Org United BioSource Corporation
Protocol Number D589BL00003
Site Investigator R. Schwartz, MD
Status Active Enrolling
Name of Compound/Drug IMX-150
Protocol Title A Randomized, Phase II, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Response study of an Aqueous Topical Formulation of Nitroglycerin, IMX-150, in the Treatment of Pain in Diabetic Peripheral Neuropathy of the Feet
Sponsor International Medical Innovations, Inc.
Protocol Number 01-004A
Site Investigator R. Schwartz, MD
Status Not Active
Name of Compound/Drug Venlafaxine Extended-Release, Selective Serotonin Reuptake Inhibitors
Protocol Title An Open-Label, Randomized, Rater-Blinded Study to Compare Rate of Remission in patients with Major Depressive Disorder Treated with Venlafaxine Extended-Release versus Selective Serotonin Reuptake Inhibitors Using Treatment Algorithms.
Sponsor Wyeth-Ayerst Pharmaceuticals
Protocol Number
Site Investigator R. Schwartz, MD
Status Not Active
Name of Compound/Drug Insulin Dry Powder Pulmonary Inhaler (Exubera®)
Protocol Title A One-Year, Open-Label Outpatient, Parallel Group Trial Assessing the Impact of the Availability of Inhaled Insulin (Exubera®) on Glycemic Control in Patients with Type 2 Diabetes Mellitus who are Poorly Controlled on a Minimum of Two Oral Anti-Diabetic Agents
Sponsor Pfizer Pharmaceuticals, Inc.
Clinical Research Org Kendle
Protocol Number A2171018
Site Investigator A. Bryan, MD
Status Not Active
Name of Compound/Drug n/a
Protocol Title A Multi-National, Multi-Center, Double-Blind, Randomized, Parallel Group Study to Compare the Safety and Efficacy of 200 mg PAR 101 Taken q12h with 125 mg Vancomycin Taken q6g for Ten Days in Subjects with Clostridium difficile-Associated Diarrhea
Sponsor Optimer Pharmaceuticals
Clinical Research Org Advanced Biologics, New Hope, PA
Protocol Number PAR-101.1.C.004
Site Investigator R. Schwartz, MD
Status Not Active
Name of Compound/Drug Celebrex®
Protocol Title Study of the Efficacy and Tolerability of Once Daily Celebrex® (celecoxib) and Twice Daily Naproxen vs. Placebo in the Treatment of Hispanic Subjects with Osteoarthritis of the Knee.
Sponsor Pfizer Pharmaceuticals, Inc.
Clinical Research Org Omni Care
Protocol Number Pfizer A3191172
Site Investigator R. Schwartz, MD
Status Not Active